No Data
BridgeBio Pharma : FDA Approves Heart Disease Drug 'Acoramidis'
Express News | BridgeBio Pharma Inc - Grants Bayer Rights to Commercialize Acoramidis in Europe
Express News | BridgeBio Pharma Inc - to Receive $500 Million Payment Under Royalty Agreement
Express News | BridgeBio Pharma Inc - FDA Approves Attruby for Treatment of Attr-Cm
Express News | Attruby™ (Acoramidis), a Near Complete Ttr Stabilizer (≥90%), Approved by FDA to Reduce Cardiovascular Death and Cardiovascular-Related Hospitalization in Attr-Cm Patients
Trading Halt: Halted at 4:08:53 P.m. ET - Trading Halt: Halt News Pending
No Data
No Data